Marco Peviani
Has grant
Assitant Professor (RTDB)
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Marco Peviani is an Assistant Professor at the University of Pavia, Italy. His research areas include neuroinflammation, immune system interactions with nanoparticles, and innovative therapeutic approaches for neurological disorders. His recent articles cover essential amino acid supplementation in stroke patients, the development of sigma-1 receptor modulators, and advancements in hematopoietic stem cell gene therapy.
Recent Grants
Grant: Close
Microglia-Targeted MRI/PET Traceable Nanovectors: Theranostic Platform for Tracking and Shaping Microglia Reactivity to Improve ALS Therapy
Open Date: 2017-03-01
Close Date: 2020-02-01
Grant: Close
Development of microglia-targeted MRI/PET traceable nanovectors as innovative theranostic platform for investigating and shaping microglia reactivity to improve ALS therapy
Open Date: 2016-12-01
Close Date: 2018-11-01
Grant: Close
Microglia-Targeted MRI/PET Traceable Nanovectors: Theranostic Platform for Tracking and Shaping Microglia Reactivity to Improve ALS Therapy
Open Date: 2015-10-01
Close Date: 2016-09-01
Articles (8)
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (9)
Bernhard Wünsch
Professor
Westfälische Wilhelms-Universität Münster
Gianluca Brugnara
University Hospital Heidelberg
Umberto Laforenza
University of Pavia
MILENA LILLINA SORRENTI
Professor
University of Pavia
Valentina Poletti
Assistant Professor of Genetics and Microbiology
University of Padua
Eleonora Cavalca
Collaboratore professionale di ricerca sanitaria
Fondazione IRCCS Istituto Neurologico Carlo Besta
Jihyae Ann
Associate Research Professor
Seoul National University
Simona Collina
University of Pavia
Arianna Rossetti
Assistant Professor
Politecnico di Torino
Make your next move.
Prepare your application
Review drafts before you send them.